NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Stock-based compensation, 2025
- DKK 1.4B
- YoY, 2025
- −37.3%
- 5-year CAGR
- +11.8%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | DKK 1.4B | −37.3% |
| 2024 | DKK 2.3B | +6.5% |
| 2023 | DKK 2.1B | +39.6% |
| 2022 | DKK 1.5B | +48.0% |
| 2021 | DKK 1.0B | +26.4% |
| 2020 | DKK 823M | +126.7% |
| 2019 | DKK 363M | — |